In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobials

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 6, 2015, Pages 3596-3597

  Barth, Natália ^a,b   Ribeiro, Vanessa B ^a,c   Zavasckid, Alexandre P ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; IMIPENEM; MEROPENEM; POLYMYXIN B; TIGECYCLINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; DRUG COMBINATION; MINOCYCLINE; THIENAMYCIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; DRUG POTENTIATION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; KPC 2 PRODUCING ENTEROBACTERIACEAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SERRATIA MARCESCENS; ANALOGS AND DERIVATIVES; DRUG COMBINATION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG COMBINATIONS; ENTEROBACTERIACEAE; IMIPENEM; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; POLYMYXIN B; SERRATIA MARCESCENS; THIENAMYCINS;

EID: 84929629956     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00365-15     Document Type: Article

References (11)

1. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. 2013. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785-796. http://dx.doi.org/10.1016/S1473-3099(13)70190-7.
2. Zavascki AP, Bulitta JB, Landersdorfer CB. 2013. Combination therapy for carbapenem-resistant Gram-negative bacteria. Expert Rev Anti Infect Ther 11:1333-1353. http://dx.doi.org/10.1586/14787210.2013.845523.
3. Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL. 2014. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 20:862-872. http://dx.doi.org/10.1111/1469-0691.12697.
4. Zavascki AP. 2014. Polymyxins for the treatment of extensively-drugresistant Gram-negative bacteria: from pharmacokinetics to bedside. Expert Rev Anti Infect Ther 12:531-533. http://dx.doi.org/10.1586/14787210.2014.902307.
5. Stein GE, Babinchak T. 2013. Tigecycline: an update. Diagn Microbiol Infect Dis 75:331-336. http://dx.doi.org/10.1016/j.diagmicrobio.2012.12.004.
6. Ribeiro VB, Andrade LN, Linhares AR, Barin J, Darini AL, Zavascki AP, Barth AL. 2013. Molecular characterization of Klebsiella pneumoniae carbapenemase-producing isolates in southern Brazil. J Med Microbiol 62:1721-1727. http://dx.doi.org/10.1099/jmm.0.062141-0.
7. Humphries RM. 2015. Susceptibility testing of the polymyxins: where are we now? Pharmacotherapy 35:22-27. http://dx.doi.org/10.1002/phar.1505.
8. Betts JW, Phee LM, Hornsey M, Woodford N, Wareham DW. 2014. In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother 58:3541-3546. http://dx.doi.org/10.1128/AAC.02449-14.
9. Zusman O, Avni T, Leibovici L, Adler A, Friberg L, Stergiopoulou T, Carmeli Y, Paul M. 2013. Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother 57:5104-5111. http://dx.doi.org/10.1128/AAC.01230-13.
10. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21th informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.